Objective: In stunned myocardium oxygen consumption is relatively high compared with the reduced ventricular function. On the other hand, inotropic stimulation is frequently required to improve postischemic ventricular dysfunction. However, inotropic agents which act via intracellular increased calcium result in a higher oxygen demand. Therefore Ca 21 -sensitization might be a favorable alternative. Methods: The effects of a novel Ca 21 -sensitizer (EMD 60263, 10 mM, group 1) were compared with a phosphodiesterase (PDE) III-inhibitor (enoximon, 20 mM, group 2) on 14 isolated, blood-perfused rabbit hearts during reperfusion after a global ischemia of 20 min. Ventricular function, the pressure±volume area (PVA, a measure of total mechanical work), and total myocardial oxygen consumption (MVO 2 ) were assessed. Contractile ef®ciency (EF cont ), derived from the reciprocal of the slope of the MVO 2 ±PVA relation, and external ef®ciency (EF ex , stroke work/MVO 2 ), were calculated. Results: At matched heart rate (group 1: 141^10 min 21 group 2: 151^28 min
Introduction
After brief episodes of ischemia, myocardial function remains depressed for hours or even days. The phenomenon of myocardial stunning is characterized by impairment of contractile function, despite almost complete integrity of the myocardium and restoration of normal or near normal coronary blood¯ow, i.e. oxygen supply [1] . Myocardial oxygen consumption is reported to be relatively high compared with postischemic function, supporting evidence that energy utilization is disturbed [2, 3] .
However, while baseline ventricular function is depressed, inotropic stimulation is often required in the clinical setting. Stunned myocardium retains the capacity to respond to various inotropic interventions [6] . Via activation of b -adrenoceptors or selective inhibition of phosphodiesterase isoenzymes, inotropic stimulation can be achieved by increasing the amount of intracellular calcium, cycled with each beat [4, 7] . Thus, this pathway is accompanied with higher energy demand, whereas the energy supply is often limited in stunned myocardium. Newer inotropic agents which act by altering myo®lament calcium sensitivity without increasing intracellular calcium levels might achieve an inotropic action with smaller increases European Journal of Cardio-thoracic Surgery 18 (2000) 83±89 of energy demand [5] . The purpose of this study was to evaluate the consequences of inotropic stimulation on myocardial energetics in stunned myocardium. We investigated the effects of a phosphodiesterase inhibitor (enoximon) and a novel calcium sensitizer (EMD 60263), a thiadiazinone derivative, on myocardial ef®ciency in isolated rabbit hearts.
Materials and methods

Experimental preparation
The experiments were performed on a total of 14 male New Zealand White rabbits with an average age of 6 months and an average weight of 2200^200 g; the rabbits were handled according to the animal welfare regulations of the German federal authorities. After rapid excision, the hearts were connected to a modi®ed Langendorff setting and perfused with a modi®ed, erythrocytes enriched Krebs± Henseleit solution containing (in mM): NaCl 119, NaHCO 3 25, KCl 4.7, CaCl 2 1.8, MgCl 2 1.2, EDTA 0.5 and glucose 11. The buffer was equilibrated with 72% N 2 , 22% O 2 , 6% CO 2 at 378C, giving a pH of 7.4. Bovine erythrocytes were added to achieve a hemoglobin concentration of 10 g/100 ml. The solution contained 4 g/100 ml albumin, and the Ca 21 concentration was adjusted to 2.5 mM.
A water-®lled latex balloon was inserted into the left ventricular cavity via the left atrium. The balloon was connected to a`systemic' circuit that contained two arti®cial valves and a windkessel. The aortic¯ow was measured via an ultrasonic¯owprobe (T 206, Transonic Systems), aortic pressure (afterload) with a pressure transducer (P 23 II, Statham). The circuit permitted changes in afterload and in preload conditions without alteration of coronary perfusion pressure. A 3-F microtip manometer (SPR-249, Millar), inserted into the balloon, was used to measure left ventricular pressure. For measurement of left ventricular dimensions, sonomicrometry was employed (system 6, Triton) using two ultrasonic crystals, glued to either side of the balloon. Different balloon sizes were used depending on the heart size.
Total coronary blood¯ow (CBF) was drained and measured with a second ultrasonic¯ow-probe. The difference in arteriovenous O 2 content (avD-O 2 ) was continuously measured using absorption spectrophotometry (AVOX systems). Arterial and venous samples of the perfusion medium were measured by a Lex-O 2 -Con analyzer to control arterial equilibration and coronary venous measurements.
Experimental protocol
Control conditions were recorded after stabilization of left ventricular function, i.e. 20 min after the end of the instrumentation. The hearts were pseudo-randomized into two groups. The hearts of each group (n 7) were subjected to a period of 20 min normothermic, no-¯ow ischemia. After 30 min reperfusion, data were recorded again, and ®nally the inotropic agents were administered. In group 1, the calcium-sensitizer EMD 60263 with a concentration of 10 mM was added. In group 2, the phosphodiesterase inhibitor III enoximon at a concentration of 20 mM was used.
During control and reperfusion, coronary arterial pressure was held constant at 80^2 mmHg. All variables were measured at a constant temperature of 37.0^0.58C maintained by immersing the hearts in a temperature-controlled chamber. For baseline measurements left ventricular preload, estimated via the intraventricular diameter, was maintained constant as well. The hearts were weighed at the end of the protocol.
In order to assess the end-systolic pressure±volume relationship ( Fig. 1) , ®ve to seven increasing preloading conditions were chosen by stepwise lifting the preload reservoir. Data were recorded after stabilization at each particular preload, and the data were acquired during control, after 30 min reperfusion and after administration of the inotropic agents. Fig. 1 . The end-systolic pressure±volume relationship (ESPVR) was constructed by linear ®tting of ®ve to seven pairs of end-systolic pressures and volumes that were obtained by preload variation (panel A). The pressure±volume are (PVA) was assessed from the area enclosed by the systolic portion of the pressure± volume (PV) loop, the ESPVR and the end-diastolic pressure volume relation (EDPVR). Five to seven MVO 2 and PVA pairs were linearly ®tted for construction of the MVO 2 ±PVA relationship (panel B). The MVO 2 -intercept of this relationship is identical to the MVO 2 of the unloaded contraction.
Data acquisition
The following variables were continuously registered on a forced-ink chart recorder (Type 481, Brush): aortic¯ow, coronary¯ow, left ventricular (LV) pressure and inner diameter. Heart rate and LV dP/dt were derived from the pressure signal. At steady-state conditions after preload alteration, the variables were simultaneously stored digitally for later analysis at a sampling rate of 300 Hz.
Calculations and statistics
Hemodynamic data were computer-assisted analyzed with six to eight consecutive beats being averaged. The end-systolic pressure±volume relationship and the pressure±volume areas were calculated with the help of the computer program EASYDAT [8] . Coronary blood¯ow was normalized to 100 g wet weight. Myocardial oxygen consumption was calculated according to the Fick principle from normalized coronary blood¯ow and the difference in oxygen content of arterial and coronary venous perfusion medium.
The contractile ef®ciency (EF cont ) was determined as the inverse slope of the MVO 2 -pressure±volume area relationship ( Fig. 1) , and the MVO 2 for the unloaded contraction was assessed as the intercept of the MVO 2 -pressure±volume area relationship with the MVO 2 axis. As an index of external ef®ciency (EF ex ), the ratio of stroke work and myocardial oxygen consumption was determined at the same inner diameters, i.e. same preload. The stroke work in turn was calculated from the peak ventricular pressure and stroke volume.
Data are expressed as mean^SD. Statistical analysis was performed with a statistical software package (Systat). Nonischemic and postischemic data were compared by paired t-testing. Analysis of variance (ANOVA) for repeated measurements was used to test differences in hemodynamic variables within any given group. When a signi®cant overall effect was detected, a post hoc test with Bonferroni correction was performed to compare single mean values. A P value of less than 0.05 was considered indicative of a signi®cant difference.
Results
Compared with control, all systolic global variables were signi®cantly depressed in the postischemic reperfused hearts. Aortic¯ow was decreased in group 1 to 20^4% and in group 2 to 25^8% compared with preischemic levels, LVP max to 57^13 vs. 76^7%, and dP/dt max to 56^12 (group 1) and 77^9% (group 2) (Fig. 2) .
Early relaxation, as measured in terms of dP/dt min , was impaired by 33^9 and 29^9%, whereas the end-diastolic left ventricular pressure remained essentially unchanged (8^3 vs. 7^3 mmHg in group 1 and 9^2 vs. 7^3 mmHg in group 2) (Fig. 2) . Heart rate was similar in both groups during pre-and postischemic intervals (Fig. 3B) . The decrease of coronary blood¯ow was not signi®cant in both groups. Total oxygen consumption was slightly decreased by 27^17% in group 1 and by 11^8% in group 2 (Fig.  3C ). In contrast, the pressure±volume area was signi®cantly decreased by 43^16 and 33^22% (Fig. 3A) . Oxygen consumption for the unloaded contraction was not signi®-cantly changed during reperfusion (by 12^5% in group 1 and by 8^6% in group 2) (Fig. 3D) . After administration of either agent, ventricular function was signi®cantly improved. Aortic¯ow, LVP max , dP/ dt max and dP/dt min were improved to almost control levels in both groups, whereas PVA was more improved by the calcium sensitizer (to 99^17% of control) compared with enoximon (to 89^13% of control value). Enoximon increased heart rate signi®cantly by 30^9% compared with control. In contrast, EMD 60263 reduced heart rate (13^13%), without reaching signi®cance. Analyzing the cardiac rhythm from the left ventricular pressure signal showed that application of either inotropic agent did not result in an increased occurrence of arrhythmias. Myocardial oxygen consumption was slightly increased above control with EMD 60263 (107^9%), but enoximon raised MVO 2 signi®cantly to 139^13% compared with control levels.
Both ef®ciency indices were signi®cantly diminished during reperfusion (Fig. 4) . External ef®ciency was decreased to 14^9% in group 1 and to 23^7% in group 2. EMD 60263 improved the external ef®ciency index to control levels (109^21%), enoximon to 57^13% of control. The contractile ef®ciency ± the reciprocal of the slope of the MVO 2 ±PVA relation ± was signi®cantly depressed in both groups, to 71^7% in the Ca 21 -sensitizer group and to 65^9% in the enoximon group. After administration of EMD 60263, EF cont was non-signi®cantly increased to 84^11% of preischemic value and after enoximon, EF cont remained almost unchanged compared with reperfusion (71^12% of control value). MVO 2 for the unloaded contraction increased non-signi®cantly by 15^6% in group 1 and 23^8% in group 2.
Discussion
The relationship between ventricular function and myocardial oxygen consumption was investigated in stunned myocardium and after application of two different inotropic agents. The major ®ndings were: (1) the calciumsensitizer EMD 60263 and the phosphodiesterase (PDE) III inhibitor enoximon, recruited an inotropic reserve; (2) myocardial ef®ciency indices remained depressed after application of enoximon, whereas EMD 60263 improved both ef®ciency indices.
Depressed contractile function in viable myocardium at almost restored coronary¯ow, i.e. oxygen and energy supply, are major characteristics of stunned myocardium [1, 2] . Possible causes underlying this phenomenon are free radical damaging of membranes and enzymes [9] , calcium overload during ischemia and early reperfusion with activation of proteases and alteration of intracellular calcium-cycling [12] . In accordance with the literature, our data show a signi®cant reduction of all functional parameters.
The relationship between ventricular function and myocardial oxygen consumption was investigated via the external ef®ciency. This term stresses the ratio between external work, i.e. stroke work (stroke volume times developed pressure), and the total energy demand, i.e. total myocardial oxygen consumption. In the present study, external ef®ciency was drastically reduced in both postischemic groups. Even after 30 min reperfusion, there was no substantial recovery. These results are in accordance with data from the literature; however, the decline in our data seems to be more pronounced, but the different types of ischemia (no-¯ow or low-¯ow ischemia), temperature and species might explain the difference with other studies.
Contractile ef®ciency was calculated by the relationship between MVO 2 and the pressure±volume area according to Suga and coworkers [13] . In contrast to the external ef®-ciency, the MVO 2 ±PVA concept allows partitioning of the MVO 2 in one fraction that is needed for contraction and another that is non-work related, i.e. the unloaded contraction. This separation clearly showed a decrease of contractile ef®ciency in stunned myocardium and, in turn, an inef®cient electromechanical coupling. The principal cause of myocardial stunning and loss of myocardial ef®ciency is not fully understood. Changes of energy requirements for calcium handling could increase myocardial oxygen consumption. However, there is evidence for a loss of Ca 21 -sensitivity of the myo®laments in stunned compared with normal myocardium as a major underlying mechanism. Based on experiments with isolated ferret hearts this mechanism was ®rst proposed in 1987 by Kusuoka et al. [23] . Moreover, other groups found a decrease in the Ca 21 -sensitivity of isometric tension in skinned ®bers from stunned pig myocardium [24] and in the intact ventricular muscle [12] . This alteration might implicate the increased energy demand of the myo®la-ments to generate force.
The inef®ciency of the myocardium has also been attributed to ischemia-induced injury such as uncoupling of oxidative phosphorylation [14] . However, no data exist con®rming mitochondrial uncoupling [15] . In the present study, MVO 2 for the unloaded contraction did not differ signi®cantly between normal and stunned myocardium. MVO 2 for the unloaded contraction, which contains the fraction for basal metabolism and another for excitation± contraction coupling, increases with increasing contractile state and decreases with decreasing contractile state [16] . Therefore, our results suggest that the maintained MVO 2 for the unloaded contraction is inadequately high in relation to the decreased postischemic contractile state. In a previous study of our group, basal MVO 2 after KCl arrest was assessed in a similar protocol. Basal MVO 2 was not elevated in postischemic hearts, suggesting that the fraction of MVO 2 attributable to excitation±contraction is disproportionately high in stunned myocardium [17] . Therefore the excess oxygen utilization at a state of reduced contractile function cannot be explained by an increased metabolic need for postischemic repair mechanisms taking place during this condition [8] and indeed, calcium transport mechanisms of cell membranes and the sarcoplasmic reticulum are impaired in stunned myocardium [10, 11] .
Inotropic support is often necessary for the long-lasting myocardial dysfunction after brief periods of ischemia, i.e. perioperatively in cardiac surgery patients after ischemic arrest. Most of the clinically used inotropic drugs, such as a -and b-adrenergic agonists, and PDE III-inhibitors, act by increasing Ca 21 -loading of the cytosol and sarcoplasmic reticulum, leading to an increase of the Ca 21 transients [4] . But this is associated with a disproportionate increase in myocardial oxygen requirement [18] . A number of new cardiotonic drugs do not act through increased cytosolic calcium transients, but affect also Ca 21 -sensitization (i.e. shift in the pCa±force relation) in both skinned and intact cardiac muscle preparations [5] . Thiadiazinone derivatives vary widely in their ability to sensitize the myo®laments towards Ca 21 and to increase cellular cyclic AMP levels via their PDE III inhibitory action; the (1)-enantiomer EMD 60263 has been described as the ®rst Ca 21 -sensitizer devoid of PDE III inhibitory activity [19] . The concentration (IC 50 ) of EMD 60263 required to reach half-maximal PDE III inhibition activity is reported to be .30 mM [20] , a concentration clearly higher than the one used in our study.
The inotropic actions of the Ca
21
-sensitizer EMD 60263 and the PDE III inhibitor enoximon were tested in a constant afterload preparation to eliminate any afterload effects. In the isolated rabbit heart preparation, postischemic ventricular dysfunction was signi®cantly improved with both agents, reaching almost preischemic control levels with the selected drug concentrations. These ®ndings were not unexpected and are in accordance with the notion that ventricular function can be improved by recruiting an inotropic reserve [20] . An in vivo study in pigs demonstrated that EMD 60263 increased systolic segment shortening of stunned and nonstunned myocardium, the effect being more pronounced in stunned than in nonstunned myocardium [21] . According to the concept of loss of Ca 21 -responsiveness of the myo®-laments as a major cause of stunning, these data and our results demonstrate that Ca 21 -sensitizers are very effective inotropic agents in this particular setting of stunned myocardium. Interestingly, only enoximon increased heart rate signi®cantly, but no arrhythmogenic effects were found in the presence of either agent in the stunned myocardium.
The external ef®ciency was substantially improved to control levels with EMD 60263 (109%), whereas EF ex remained depressed with enoximon (57%). After administration of both drugs, contractile ef®ciency was slightly increased with EMD 60263 and remained unchanged with enoximon. With respect to the better improvement of myocardial ef®ciency with the Ca 21 -sensitizer compared with the PDE III inhibitor, the present data also underline the reduced Ca 21 -responsiveness as a major cause for energy wastage in the stunned myocardium. Therefore, Ca
-sensitization also improves the energetic balance, whereas other inotropic agents do not. Another advantage of Ca 21 -sensitization compared with phosphodiesterase inhibition, with its known vasodilatory effects, might be that no systemic vasodilatory properties were seen. This was shown in an in vivo study in pigs [21] . However, despite the quite interesting perspectives of Ca 21 -sensitization in the management of postoperative heart failure, there are only a few clinical trials with the agent Levosimendan. In a clinical study, this Ca 21 -sensitizer, which also has phosphodiesterase-inhibiting properties, showed an enhancement of cardiac performance after cardiopulmonary bypass in humans [25] .
The MVO 2 ±PVA relationship has been shown to be more sensitive in the settings of ischemia [22] compared with other ef®ciency assessments. The absence of complete recovery of contractile ef®ciency, even after Ca 21 -sensitization, indicates that in stunned myocardium energy utilization is disturbed and can scarcely be improved.
Conclusion
In our model of myocardial stunning, the imbalance of oxygen consumption to decreased ventricular function, as demonstrated by the decline of ef®ciency indices, shows the energetic inef®ciency of the myocardium. Ca 21 -sensitization and PDE III inhibition both can recruit an inotropic reserve. Because Ca 21 -sensitization seems to be more favorable in terms of myocardial ef®ciency, we conclude that Ca 21 -desensitization is an attribute of the phenomenon of myocardial stunning. The maintained MVO 2 for the unloaded contraction in stunned myocardium and its moderate change after Ca 21 -sensitization also indicate that disturbances in excitation±contraction coupling contribute to the inef®ciency. Taken together, concerning myocardial ef®-ciency the Ca 21 -sensitizer seems to exert more bene®cial effects in postischemic inotropic stimulation.
